Zymosan
| Product Name | Zymosan |
|---|---|
| Alternate Names | - Carbohydrates, Carbohydrates of - |
| CAT No. | CS-O-51509 |
| CAS No. | 9010-72-4 |
| Category | Carbohydrates |
| Stock | Enquire |
| Mol. Wt. | - g/mol |
| Mol. For. | - |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | - |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Get an Instant Quote
Related Compounds
GT3sph d18:1 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbSphingolipids) | Galc d18:1/16:1（GalaCeramide） | iGB4Cer d18:1/18:0-Biotin (GalNAcb1,3Gala1,3Galb1,4GlcbCeramide-Biotin) | FucGM1Cer d20:1/12:0 ((Fuca1,2)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GM2Cer d18:1/24:1 (GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GD1aCer d18:1/16:0 ((Neu5Aca2,3)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | Sialyl-iGb5 | GD1bCer d18:1/12:0 (Galb1,3GalNAcb1,4(Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | LS-tetrasaccharide c | GQ3Cer d20:1/24:1 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | Glucoerucin potassium salt | GD3Cer d18:1/8:0 (Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | FucGM1sph d20:1 ((Fuca1,2)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbSphingolipids) | GM2Cer d18:1/18:0-Biotin (GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide-Biotin) | Neu5Gca2-3Lea-sp-biotin | GM1aCer d20:1/16:0 (Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | FucGM1Cer d20:1/8:0 ((Fuca1,2)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GlcNAcproN3 | GT1csph d20:1 (Galb1,3GalNAcb1,4(Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbSphingolipids) | GT1cCer d18:1/16:0 (Galb1,3GalNAcb1,4(Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | FucGM1Cer d18:1/8:0 ((Fuca1,2)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GQ3Cer d18:1/12:0 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | FucGM1sph d18:1 ((Fuca1,2)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbSphingolipids) | GlcCer d20:1/20:0 (GlcbCeramide) | GT3 | ALewis B (ALe b ) | GD1bsph d18:1 (Galb1,3GalNAcb1,4(Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbSphingolipids) | Epiprogoitrin potassium salt | GlcNAcb1, 3Galb1, 4(Fuca1, 3)GlcNAc | GM1bCer d18:1/18:0-Biotin ((Neu5Aca2,3)Galb1,3GalNAcb1,4Galb1,4GlcbCeramide-Biotin) | Lc3 | GT1csph d18:1 (Galb1,3GalNAcb1,4(Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbSphingolipids) | Neu5Aca2,3Galb1,4(Fuca1,3)(HSO4-6-)GlcNAc | GM1aCer d18:1/16:0 (Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GB4Cer d18:1/18:0-Biotin (GalNAcb1,3Gala1,4Galb1,4GlcbCeramide-Biotin) | GM3Cer d20:1/20:0 (Neu5Aca2,3Galb1,4GlcbCeramide) | GM3Cer d18:1/18:0 (Neu5Aca2,3Galb1,4GlcbCeramide) | Lewis Y (Le Y) | SSEA-4 | GM3sph d20:1 (Neu5Aca2,3Galb1,4GlcbSphingolipids) | GT2Cer d18:1/16:0 (GalNAcb1,4(Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | GD1aCer d20:1/18:0 ((Neu5Aca2,3)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | FucGM1Cer d20:1/16:0 ((Fuca1,2)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GM2Cer d18:1/12:0 (GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GD1bCer d20:1/16:0 (Galb1,3GalNAcb1,4(Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | Ac3 6-AzManNAc | Blood type trisaccharide H Type III/IV | Glucolepidiin potassium salt | Glucobrassicine | GD2Cer d18:1/16:0 (GalNAcb1,4(Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | GT2 | Ac4 ManNAc | Blood type trisaccharide A | GT3Cer d20:1/12:0 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | GM1aCer d18:1/24:1 (Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GM1bCer d18:1/20:0 (Neu5Aca2,3Galb1,3GalNAcb1,4Galb1,4GlcbCeramide) | D-galactosyl-α-1,1' N-palmitoyl-D-erythro-sphingosine | GT3Cer d20:1/16:0 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | GT3Cer d18:1/24:1 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | Blood type trisaccharide H Type VI (2'FL) | Lactose-PEG-N3 | Sialyl-Lc4 | GM2Cer d18:1/20:0 (GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GM2Cer d18:1/16:0 (GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GM2Cer d18:1/20:0 (GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GlcCer d20:1/16:0 (GlcbCeramide) | GT3Cer d20:1/18:0 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | P(Galb1,3Gala1,4Galb1,4GlcbR) | Galc d18:1/18:1（GalaCeramide） | Bortezomib D-mannitol |